Easy to use, low-cost molecular-based sars-COV-2 test, highly scalable rapid acceleration of diagnostics (RADX) program: tech project #2244 mesa biotech, INC.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92020C00014
- Awardee
-
Mesa Biotech Inc. UEI NCEGPN78SNF7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,860,014
Award facts
- Contract value 100% obligated
- $24,860,014.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$9,866,750 | |
| Other Administrative Action | $0 | |
| Definitize Change Order | $0 | |
| Exercise an Option | $9,691,500 | |
| Definitize Change Order | $9,691,500 | |
| Other Administrative Action | $0 | |
| Definitize Change Order | $0 | |
| Exercise an Option | $294,500 | |
| Definitize Letter Contract | $9,057,660 | |
| Other Administrative Action | $1,000,000 | |
| Original award | $4,991,604 |
Show all 11
About this award
This is a $24,860,014.00 firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Mesa Biotech Inc. for the development of an easy-to-use, low-cost molecular-based SARS-CoV-2 test. The contract is part of the Rapid Acceleration of Diagnostics (RADx) program, which aims to accelerate the development, validation, and commercialization of innovative COVID-19 testing technologies. The contract has a performance period ending on May 4, 2024, and does not have a set-aside designation.
Quick answers
Who was awarded contract 75N92020C00014?
75N92020C00014 was awarded to Mesa Biotech Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 30, 2020.
How much is contract 75N92020C00014 worth?
The government has obligated $24,860,014 on 75N92020C00014.
Was contract 75N92020C00014 competed?
The extent of competition for 75N92020C00014 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award